(Source: Transgene SA) Transgene Announces the Nomination of two new Board Members Prof. Laurence Zitvogel (MD) and Mr Jean-Luc Bélingard were elected to the board at the AGM held on June 19, 2013 Strasbourg, France, June 26, 2013 - Transgene SA (Euronext Paris: TNG), a biopharmaceutical company that develops immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, today announced that two new members of the board were elected at the Annual General Meeting held on June 19, Prof. Laurence Zitvogel and Mr Jean-Luc Bélingard, in replacement respectively of Prof. Christian Bréchot (MD) and Mr Georges Hibon who did not stand for reelection. Ms...
↧